RHOD and breast cancer: Our results using publicly available datasets show a relatively low frequency of amplifications and copy number alterations within TGCA for RHOD (Tables 4 and 5) and a prognostic role of RHOD in both RFS and OS of oestrogen receptor positive breast cancer (Fig. 7).